CHEMO IBERICA
CHEMO IBERICA, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Spain and operates extensively across Europe and Latin America. Founded in 1985, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a diverse portfolio that includes oncology, anaesthesia, and critical care products, CHEMO IBERICA is renowned for its commitment to innovation and quality. The company’s state-of-the-art facilities and rigorous quality control processes ensure that its offerings meet the highest industry standards. Recognised for its significant contributions to healthcare, CHEMO IBERICA continues to expand its market presence, driven by a dedication to improving patient outcomes and a strong focus on research and development.
DitchCarbon Score
How does CHEMO IBERICA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CHEMO IBERICA's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CHEMO IBERICA's reported carbon emissions
CHEMO IBERICA currently does not provide specific carbon emissions data for the most recent year, as there is no available information on their emissions in kg CO2e. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions figures, it is important to note that many companies in the chemical industry are increasingly focusing on sustainability and reducing their carbon footprint. This often includes commitments to improve energy efficiency, transition to renewable energy sources, and implement innovative technologies to lower emissions across all scopes. While CHEMO IBERICA has not disclosed specific targets or achievements, the industry context suggests a growing emphasis on climate commitments, which may include aligning with global standards such as the Science Based Targets initiative (SBTi) in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CHEMO IBERICA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
